Project Details
Short title | BLast:A confirmatory multicenter, single-arm study to assess the efficacy, safety and tolerability of the BITE antibody blinatumomab in adult patients with minimal residual disease (MRD) of B-precursor acute lymphoblastic leukaemia |
---|---|
Status | Finished |
Effective start/end date | 26/07/11 → 31/12/15 |
Funding
- Queen Elizabeth Hospital Birmingham